SELADELPAR AND REDUCTIONS IN LIPIDS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS WITH AND WITHOUT STATIN USE IN THE PHASE 3 PLACEBO-CONTROLLED RESPONSE STUDY
HEPATOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined